Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Chemokine as proinflammatory signal after traumatic brain injury

Nov. 16, 2011

PBI-4050 demonstrates nephroprotection in animal models

Nov. 16, 2011

AMG-145 assessed in first-in-human trial

Nov. 16, 2011

Phase II results reported for miravirsen

Nov. 16, 2011

Phase III trial of vorapaxar does not meet primary endpoint

Nov. 15, 2011

Cancer therapy Lipotecan advances through first-in-human trial

Nov. 15, 2011

Novel voltage-gated K(V)7 potassium channel modulator has anticonvulsant activity

Nov. 15, 2011

Effect of hepatic impairment on single-dose pharmacokinetics of daclatasvir investigated

Nov. 15, 2011

New PAI-1 inhibitor ameliorates experimental collapsing focal segmental glomerulosclerosis

Nov. 15, 2011

Analgesia seen with NP-2 in phase I study

Nov. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...